A Study of Trial of windose Active Ingrediet ANDRO GRAP HOLIDEP articulate an Extract of enriched KALMEGH or KALMEGHA Extract (Kalmegh or kalamegha) or Nilavembu root extract&caripill or caripappa (papaya leave extract) in the treatment of Dengue, Chicken guniya & post viral arthritis

International Journal of Medical Science

© 2017 by SSRG - IJMS Journal

Volume 4 Issue 12

Year of Publication : 2017

Authors : Dr. An. Kalanitthi, Dr. Kanimozhi Baskaran

10.14445/23939117/IJMS-V4I12P104

How to Cite?

Dr. An. Kalanitthi, Dr. Kanimozhi Baskaran, "A Study of Trial of windose Active Ingrediet ANDRO GRAP HOLIDEP articulate an Extract of enriched KALMEGH or KALMEGHA Extract (Kalmegh or kalamegha) or Nilavembu root extract&caripill or caripappa (papaya leave extract) in the treatment of Dengue, Chicken guniya & post viral arthritis," SSRG International Journal of Medical Science, vol. 4,  no. 12, pp. 17-19, 2017. Crossref, https://doi.org/10.14445/23939117/IJMS-V4I12P104

Abstract:

Severe Fever with Thrombocytopenia syndrome. This is recently described tick-borne disease caused by previously and still unclassifiedphlevovirus. A virological diagnosis of severe Dengue can be made by the usual means initially caused by a mosquito “A- Aegypti”. This study focus on theuse of papaya leave extractof ErandaKarkatiandNilavembu root extract (Kalmegh or kalamegha). The common name comes from theTaino wordpapaia that was changed in spanish to papaya the word mostly usedworld wide, with some changes. In Australia & some countries of the caribben the friuit is called “PaPaw”or“Paw Paw”. Botanical Name: “Carica papaya” HIGHLIGHTS :- In the recent decade, dengue has re-emerged and with it being endemic in more than 110 countries, it has been the most prevalent arthropod-borne viral diseases in terms of morbidity and mortality. Two-fifths of the world populations are at risk, estimating around 100 million of dengue fever infections, 2.1 million cases of dengue hemorrhagic fever and 200 thousand deaths worldwide are caused by dengue every year. Objective:- To study or asses the value or effectiveness of two drugs described increases the Immunity and also IncreasesWBC& Platelet count. Material & methods:- 100 cases of ViralFever with Thrombocytopenia have been admitted in KHM Hospitalwithout gender bias age ranging from 3 years to 55 years. Patientwere admitted with the platelet count 10000 to 1.2 lakhs. The Temperature was as high as 102`F – 104’F. After the administration of RL and NS 50ml/hr forchildrens& 100ml/hr for adults, with paracetamol, 650mg 3-4 times a day and incase of children according tothe weightT.Caripill 3 times daily andwindose 2 times daily were given though initially platelet count and WBC count dropped, from the 3rd dayof admission WBC and platelet were increased.

Keywords:

The drug efficiency is proved significantly good, in raising the WBC count& platelet count.

References:

1. D. Kirby, B. Laris, A. Rolleri. "Sex and HIV Education Programs: Their Impact on Sexual Behaviours of Young People throughout the World". Journal of Adolescents Health. 2007; 40(3): 206 – 217.
2. M. Gilbert, P. Thomas, A. Rambaut, G. Walsiuk, J. Thomas, E. Arthur. "The Emergence of HIV/AIDs in the Americas and Beyond. Proceedings of the National Academy of Sciences. 2007; 104(47): 18566 – 18570.
3. W. Steketee, L. Nahlen, E. Parise, C. Menendez. The Burden of Malaria in Pregnancy in Malaria-Endemic Areas. American Journal of Tropical Medical Hygiene. 2001; 164: 28 – 35.
4. World Health Organization. National Medicines List/Formulary/Standard Treatment Guidelines. Available at http://www.who.int /selection_medicines/country_lists/en/index.html. 2015.
5. R. McGready, T. Cho, V. Samuel, A. Brockman, V. Van, S. Looareesuwan, N. White, F. Nosten. Randomized Comparison of Quinine-Cindamycin versus Artesunate in the Treatment of Falciparum Malaria in Pregnancy. 2001, p 465.
6. J. Achan, J. Tibenderana, D. Kyabyinze, H. Mawejje, R. Mugizi, B. Mpeka, B., A. Talisuna, U. D’Alessandro. Case Management of Severe Malaria- a Forgotten Practice: Experiences from Health Facilities in Uganda. Plos One, 2011; 6(3): 170 – 253.
7. N. White, P. Chanthavanich, S. Krishna, C. Bunch, K. Silamut, Antimalarial Pharmacokinetics and Pharmacology. British Journal of Clinical Pharmacology, 1996; 44(2): 55 – 60.
8. S. Pukrittayakamee, S. Wanwimolruk, K. Stepniewska, A. Jantra, S. Huyakorn, S. Looareesuwn, N. White. Quinine Pharmacokinetic-Pharmacodynamic Relationship in Uncomplicated Malaria. Antimicrobial Agents and Chemotherapy. 2003; 47(11): 3458 – 3463.
9. F. Boubred, M. Vendemmia, P. Garcia-Meric, C. Buffat, V. Millet, U. Simeoni. Effects of Maternally Administered Drugs on the Fetal and Neonatal Kidney. Drug safety, 2006; 29(5): 397 -419.
10. E. Tuomala, E. Shapiro, M. Mofenson, Y. Bryson, M. Culnane, D. Hughes. Antiretroviral Therapy during Pregnancy and the Risk of an Adverse Outcome. National English Journal of Medicine. 2002; 346: 1863 – 1870.
11. C. Ashley. Renal Failure - How Drugs can damage the Kidney. Pharmaceutical Journal. 2009; 7(1): 34 – 38.
12. I. U. Umoh T. B. Ekanem, M. A. Eluwa, U. E. Bassey. Fetal Hepatorenal Toxicity of Artemether/Lumefantrine (Coartem®) in Second Trimester of Pregnancy in Albino Rats. European Journal of Pharmaceutical and Medical Research, 2017; 4(2): 240 – 246.
13. K. Anastos, M. Schechter, E. Balestre, L. Myer, A. Boulle, D. Bangsberg, H. Toure, P. Braitstein, E. Sprinz. Antiretroviral Therapy in Resource-Limited Settings 1996 to 2006: Patient Characteristics, Treatment Regimens and Monitoring in Sub-Saharan Africa, Asia and Latin America. Trop. Medical International Health, 2008; 13: 870 – 879.
14. O. Mesembe, A. Igiri, I. Naikot, V. Ekam, J. Odukana, V. Fischer. Liver and Kidney Morphologies Following Vitamin E Supplementation During Caffeinated and Non-Caffeinated Paracetamol Administration in Rats. Journal of Experimental & Clinical Anatomy, 2004; 3(1): 35 – 38.
15. X. Wei, K. Ghosh, E. Taylo, A. Johnson, A. Emini. Viral Dynamic in Human Immunodeficiency Virus Type 1 Infection. Nature, 1999; 373: 117 – 122.
16. M. Cotter. Is Antiretroviral Therapy during Pregnancy associated with an Increased Risk of Preterm Delivery, Low Birth Weight, or Stillbirth? Journal of Infectious Diseases, 2006; 193(9): 1195 – 1201.
17. M. Nelson, A. Azwa, A. Sokwala, R. Harania, J. Stebbing. Fanconi Syndrome and Lactic Acidosis Associated with Stavudine and Lamivudine Therapy. AIDS, 2008; 22: 1374 – 1376.
18. N. Hausman, K. Beharry, K. Nishihara, Y. Akmal, T. Asrat. Effect of the Antenatal Administration of Celecoxib during the Second and Third Trimesters of Pregnancy on Prostaglandin, Cytokine, and Nitric Oxide Levels in Rabbits. American Journal of Obstetric Gynecology, 2003; 189(6): 1737 – 1743.
19. S. Espiridiao, R. Oliveira-Filho, M. Simoes, J. Mamede, L. Kulay. Liver and Kidney Ultrastructural Changes caused by Acetylsalicylic Acid Treatment during Pregnancy in Rats. Clinical and Experimental Obstetric Gynecology, 2002; 29(1): 37 – 39.
20. S. Devipriya, D. Shamala. Protective Effects of Quercetin in Cisplatin-Induced Cell Injury in the Rat Kidney, Indian Journal of Pharmacology, 1999; 3: 422 – 426.
21. E. Meral, E. Levent, N. Yusuf, K. walker. The Effects of Nifedipine on Renal Perfusion Pressure and Kidney during Cisplatin-Induced Nephrotoxicity in Rats. Dicle. Tıp. Dergisi. Cilt, 2007; 34(4): 248 – 253.
22. H. Kajino, C. Roman, R. Clyman. Renal Effects of Cyclooxygenase-2 Inhibition in Fetal Lambs. Biological Neonate, 2002; 82(4): 257 – 262.
23. A. Shirwaikar, S. Malini, C. Kumari. Protective Effect of Pongamia pinnata Flowers against Cisplatin and Gentamicin Induced Nephrotoxicity in Rats. International Journal of Experimental Biology, 2003; 4: 58 – 62.
24. E. Daugas, P. Rougier, G. Hill. HAART-Related Nephropathies in HIV-Infected Patients. Kidney International, 2005; 67: 393 – 403.
25. H. Izzedine, V. Launay-Vacher, G. Deray. Antiretroviral Drug-Induced Nephrotoxicity. American Journal of Kidney Disease, 2005; 45: 804 – 817.
26. M. Ahmad. Abacavir-Induced Reversible Fanconi Syndrome with Nephrogenic Diabetes Insipidus in a Patient with Acquired Immunodeficiency Syndrome. Journal of Postgraduate Medicine, 2006; 52: 296 – 297.
27. A. Menahem, J. Perry, J. Dowling, M. Thomson. Hypokalaemia-Induced Acute Renal Failure. Nephrology Daily Transplant, 1999; 14: 2216 – 2218.
28. G. D'Ythurbide, C. Goujard, F. Mechai, A. Blanc, B. Charpentier, R. Snanoudj. Fanconi Syndrome and Nephrogenic Diabetes Insipidus Associated with Didanosine Therapy in HIV Infection: A Case Report and Literature Review. Nephrology Daily Transplant, 2007; 22: 3656 – 3659.
29. C. Dobyn, J. Levi, C. Jacobs, J. Kosek, W. Weiner. Mechanism of Cis-Platinum Nephrotoxicity: Morphologic Observations, Journal of Pharmacological Experimental Therapy, 1980; 213: 551 – 556.
30. S. Alkhuja, R. Menkel, M. Alwarshetty, A. Ibrahimbacha. Celecoxib-Induced Nonoliguric Acute Renal Failure. Pharmaceutical therapy, 2002; 36(1): 52 – 54.
31. D. Brater. Renal Effects of Cyclooxygyenase-2- Selective Inhibitors. Journal of Pain Symptom Manage, 2002; 23: 15 – 20.